150 related articles for article (PubMed ID: 34587846)
1. The Prevalence of Drug-Drug Interactions with Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in the Intensive Care Unit.
Johnston JP; Heavner MS; Liu M; Casal GLH; Akgün KM
J Pharm Pract; 2023 Apr; 36(2):322-328. PubMed ID: 34587846
[No Abstract] [Full Text] [Related]
2. Analysis of potential drug-drug interactions in medical intensive care unit patients.
Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
[TBL] [Abstract][Full Text] [Related]
3. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations.
Bakker T; Dongelmans DA; Nabovati E; Eslami S; de Keizer NF; Abu-Hanna A; Klopotowska JE
J Clin Pharmacol; 2022 Jun; 62(6):706-720. PubMed ID: 34957573
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
[TBL] [Abstract][Full Text] [Related]
6. Frequency and nature of drug-drug interactions in the intensive care unit.
Askari M; Eslami S; Louws M; Wierenga PC; Dongelmans DA; Kuiper RA; Abu-Hanna A
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):430-7. PubMed ID: 23420793
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
Deutschmann E; Bucher HC; Jaeckel S; Gibbons S; McAllister K; Scherrer AU; Braun DL; Cavassini M; Hachfeld A; Calmy A; Battegay M; Cipriani M; Elzi L; Young J; Lopez-Centeno B; Berenguer J; Khoo S; Moffa G; Marzolini C;
Clin Infect Dis; 2021 Oct; 73(7):e2145-e2152. PubMed ID: 32634832
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
[TBL] [Abstract][Full Text] [Related]
9. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
[TBL] [Abstract][Full Text] [Related]
10. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
[TBL] [Abstract][Full Text] [Related]
11. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit.
Croda J; Croda MG; Neves A; De Sousa dos Santos S
Crit Care Med; 2009 May; 37(5):1605-11. PubMed ID: 19325488
[TBL] [Abstract][Full Text] [Related]
12. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
13. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.
Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J
Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760
[TBL] [Abstract][Full Text] [Related]
14. Potential drug-drug interactions in ICU patients: a retrospective study.
Ali I; Bazzar A; Hussein N; Sahhar E
Drug Metab Pers Ther; 2020 Jul; 35(3):. PubMed ID: 32681774
[TBL] [Abstract][Full Text] [Related]
15. Changes in short-term (in-ICU and in-hospital) mortality following intensive care unit admission in adults living with HIV: 2000-2019.
Kanitkar T; Dissanayake O; Bakewell N; Symonds M; Rimmer S; Adlakha A; Lipman MCI; Bhagani S; Sabin CA; Agarwal B; Miller RF
AIDS; 2023 Nov; 37(14):2169-2177. PubMed ID: 37605448
[TBL] [Abstract][Full Text] [Related]
16. Relevance of drug-drug interaction in the ICU - perceptions of intensivists and pharmacists.
Askari M; Eslami S; Louws M; Dongelmans D; Wierenga P; Kuiper R; Abu-Hanna A
Stud Health Technol Inform; 2012; 180():716-20. PubMed ID: 22874285
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of potential drug-drug interactions in intensive care unit.
Dagdelen MS; Gulen D; Ceylan I; Girgin NK
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5801-5806. PubMed ID: 34604971
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
[TBL] [Abstract][Full Text] [Related]
19. Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.
Molas E; Luque S; Retamero A; Echeverría-Esnal D; Guelar A; Montero M; Guerri R; Sorli L; Lerma E; Villar J; Knobel H
HIV Clin Trials; 2018 Feb; 19(1):1-7. PubMed ID: 29179644
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Marzolini C; Elzi L; Gibbons S; Weber R; Fux C; Furrer H; Chave JP; Cavassini M; Bernasconi E; Calmy A; Vernazza P; Khoo S; Ledergerber B; Back D; Battegay M;
Antivir Ther; 2010; 15(3):413-23. PubMed ID: 20516560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
